These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25538250)

  • 1. Osteoblast menin regulates bone mass in vivo.
    Kanazawa I; Canaff L; Abi Rafeh J; Angrula A; Li J; Riddle RC; Boraschi-Diaz I; Komarova SV; Clemens TL; Murshed M; Hendy GN
    J Biol Chem; 2015 Feb; 290(7):3910-24. PubMed ID: 25538250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
    Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
    J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menin suppresses osteoblast differentiation by antagonizing the AP-1 factor, JunD.
    Naito J; Kaji H; Sowa H; Hendy GN; Sugimoto T; Chihara K
    J Biol Chem; 2005 Feb; 280(6):4785-91. PubMed ID: 15563473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menin expression is regulated by transforming growth factor beta signaling in leukemia cells.
    Zhang H; Liu ZG; Hua XX
    Chin Med J (Engl); 2011 May; 124(10):1556-62. PubMed ID: 21740816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menin and TGF-beta superfamily member signaling via the Smad pathway in pituitary, parathyroid and osteoblast.
    Hendy GN; Kaji H; Sowa H; Lebrun JJ; Canaff L
    Horm Metab Res; 2005 Jun; 37(6):375-9. PubMed ID: 16001330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-beta pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice.
    Hussein N; Lu J; Casse H; Fontanière S; Morera AM; Guittot SM; Calender A; Di Clemente N; Zhang CX
    Endocr Relat Cancer; 2008 Mar; 15(1):217-27. PubMed ID: 18310289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
    Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
    J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Bcl2 in osteoblasts inhibits osteoblast differentiation and induces osteocyte apoptosis.
    Moriishi T; Maruyama Z; Fukuyama R; Ito M; Miyazaki T; Kitaura H; Ohnishi H; Furuichi T; Kawai Y; Masuyama R; Komori H; Takada K; Kawaguchi H; Komori T
    PLoS One; 2011; 6(11):e27487. PubMed ID: 22114675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineage.
    Sowa H; Kaji H; Canaff L; Hendy GN; Tsukamoto T; Yamaguchi T; Miyazono K; Sugimoto T; Chihara K
    J Biol Chem; 2003 Jun; 278(23):21058-69. PubMed ID: 12649288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of menin in bone development.
    Kaji H; Canaff L; Hendy GN
    Adv Exp Med Biol; 2009; 668():59-67. PubMed ID: 20175453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menin and bone metabolism.
    Kaji H
    J Bone Miner Metab; 2012 Jul; 30(4):381-7. PubMed ID: 22543820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axin2 controls bone remodeling through the beta-catenin-BMP signaling pathway in adult mice.
    Yan Y; Tang D; Chen M; Huang J; Xie R; Jonason JH; Tan X; Hou W; Reynolds D; Hsu W; Harris SE; Puzas JE; Awad H; O'Keefe RJ; Boyce BF; Chen D
    J Cell Sci; 2009 Oct; 122(Pt 19):3566-78. PubMed ID: 19737815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired transforming growth factor-β (TGF-β) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1).
    Canaff L; Vanbellinghen JF; Kaji H; Goltzman D; Hendy GN
    J Biol Chem; 2012 Mar; 287(11):8584-97. PubMed ID: 22275377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic mice.
    Harrison JR; Huang YF; Wilson KA; Kelly PL; Adams DJ; Gronowicz GA; Clark SH
    J Biol Chem; 2005 Mar; 280(9):8117-24. PubMed ID: 15598659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The embryonic transcription factor Hlxb9 is a menin interacting partner that controls pancreatic β-cell proliferation and the expression of insulin regulators.
    Shi K; Parekh VI; Roy S; Desai SS; Agarwal SK
    Endocr Relat Cancer; 2013 Feb; 20(1):111-22. PubMed ID: 23419452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered MENIN expression disrupts the MAFA differentiation pathway in insulinoma.
    Hamze Z; Vercherat C; Bernigaud-Lacheretz A; Bazzi W; Bonnavion R; Lu J; Calender A; Pouponnot C; Bertolino P; Roche C; Stein R; Scoazec JY; Zhang CX; Cordier-Bussat M
    Endocr Relat Cancer; 2013 Dec; 20(6):833-48. PubMed ID: 24157940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of Sp7 in osteoblasts for the proliferation, differentiation, and osteocyte process formation.
    Jiang Q; Nagano K; Moriishi T; Komori H; Sakane C; Matsuo Y; Zhang Z; Nishimura R; Ito K; Qin X; Komori T
    J Orthop Translat; 2024 Jul; 47():161-175. PubMed ID: 39027344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional inactivation of the CXCR4 receptor in osteoprecursors reduces postnatal bone formation due to impaired osteoblast development.
    Zhu W; Liang G; Huang Z; Doty SB; Boskey AL
    J Biol Chem; 2011 Jul; 286(30):26794-805. PubMed ID: 21636574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation.
    Yang M; Trettel LB; Adams DJ; Harrison JR; Canalis E; Kream BE
    Bone; 2010 Sep; 47(3):573-82. PubMed ID: 20541046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic AMP Response Element-binding Protein H (CREBH) Mediates the Inhibitory Actions of Tumor Necrosis Factor α in Osteoblast Differentiation by Stimulating Smad1 Degradation.
    Jang WG; Jeong BC; Kim EJ; Choi H; Oh SH; Kim DK; Koo SH; Choi HS; Koh JT
    J Biol Chem; 2015 May; 290(21):13556-66. PubMed ID: 25873397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.